ATP6V0D2, which is required for osteoclast differentiation as well as the bone-resorptive function of mature osteoclasts (5, 20), was found to be expressed at higher levels in the serum of patients with HF, ACS, or CCHD than in the healthy group. Here, ATP6V0D2 is linked to hydrops fetalis.